Value in Health publishes theme section on patient preferences

The latest issue of Value in Health incudes a themed section on the incorporation of patient preferences into health care decision making.

The focus of this themed section is the use of patient-centred benefit-risk assessment to support regulatory decision making and other decision making settings.

"This is very timely issue for the PREFER project that is launching this month" says Ardine de Wit from the University Medical Center Utrecht and one of the leaders for our clinical case studies.  (Link removed)

Many of the papers are directly relevant for the project. If you are interested, please have a look at the current issue: Volume 19 Issue 6 - September/October 2016

By Josepine Fernow, Uppsala University 





  • Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.


The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).